Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: fatwollit
13
Jul 13, 2009 03:38PM
1
Jul 13, 2009 03:57PM
5
Jul 13, 2009 04:19PM
13
Jul 13, 2009 09:57PM

So, does it then follow that as feedback on investment in PDSG was positive, Baroni was hired to give an overall worth to it in order that there might be placements under Rule 506 of Regulation D?

As PDSG's offering is basically a software suite, writers to keep it updated should be affordable without the need of further cash input. However, I would have no problems with strategic investments by a few established firms within the sector, but only if their involvement substantially increased the value of PDSG.

There is always the IPO alternative, which would give maximum benefit to PTSC shareholders.

Hmmmmm, interesting.

Be well

Share
New Message
Please login to post a reply